-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures (Hipo_021)
Study
EGAS00001006629
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Whole genome analysis of pediatric patients with medulloblastoma
Study
EGAS00001006653
-
Single cell RNAseq of lung adenocarcinoma
Study
EGAS00001005021
-
Follicular lymphoma at diagnosis, treated in first line with immunochemotherapy
Study
EGAS00001006674
-
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
Study
EGAS00001006678
-
Clonal dynamics of normal hepatocyte expansions in homeostatic human livers and their association with the biliary epithelium
Study
EGAS00001006962
-
Pre-neoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Study
EGAS00001006692
-
Neoadjuvant Chemo or Combined Chemo-Radiation Therapy of Pancreatic Ductal Adenocarcinoma Yields Fundamentally Different Proteome Biology of the Residual Tumor Mass
Study
EGAS00001006739
-
Diet driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Study
EGAS00001006982
-
NIBIT-M4 Clinical Trial samples
Study
EGAS00001006736
-
Chromatin landscape of medulloblastoma reveals context dependent driver
Study
EGAS00001006741
-
Single cell multi-omic study of H3-K27M mutant diffuse midline glioma across age and location
Study
EGAS00001006994
-
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling (hipo_021)
Study
EGAS00001006747
-
The Iberian Roma genetic variant server
Study
EGAS00001006758
-
Single cell and plasma RNA sequencing
Study
EGAS00001005194
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
NEC
Study
EGAS00001007013
-
Neuroblastoma heterogeneity
Study
EGAS00001007016
-
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
Study
EGAS00001006793
-
Shot-gun stool metagenomics and colorectal cancer risk.
Study
EGAS00001007025
-
Integrated single cell analysis in transformed follicular lymphoma
Study
EGAS00001007023
-
Malignant progression of an ancestral bone marrow clone harboring a CIC-NUTM2A fusion in isolated myeloid sarcoma
Study
EGAS00001006833
-
Single cell RNA sequencing of bone marrow mononuclear cells
Study
EGAS00001006836
-
TK-EPN862 - Patient-dervied xenograft model of Posterior Fossa A Ependymoma - RNAseq
Study
EGAS00001006844
-
Identification and functional characterisation of a rare MTTP variant underlying familial non-alcoholic fatty liver disease
Study
EGAS00001005254
-
Tracing early predictors of glioma evolution under therapy
Study
EGAS00001006894
-
Tracking the evolution of Therapy-Related Myeloid Neoplasms using chemotherapy signatures
Study
EGAS00001006903
-
Genomic profiling of localized (lFL) and systemic follicular lymphoma (sFL) reveals novel insights into FL pathogenesis
Study
EGAS00001006927
-
Bolleboom-Gao peri-tumoral snRNA-seq glioblastoma dataset 2022/A
Study
EGAS00001006935
-
The immunological characterization of expanded tumor-infiltrating lymphocytes in renal cell carcinoma patients
Study
EGAS00001006952
-
A novel Patient-Derived 3D Model Recapitulates Mantle Cell Lymphoma Lymph Node Signaling, Immune Profile and in vivo Ibrutinib Responses
Study
EGAS00001006964
-
Linked-read based analysis of Medulloblastomas
Study
EGAS00001007064
-
scRNA-seq of total bone marrow mononuclear cells and CD3+ T cells of multiple myeloma patients and healthy donors
Study
EGAS00001006980
-
Study of complex rearrangements and mutational signatures in neuroblastoma heterogeneous risk groups.
Study
EGAS00001006983
-
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild type primary glioblastoma
Study
EGAS00001006989
-
CAGEKID: Cancer Genomics of the Kidney - Targeted Sequencing
Study
EGAS00001007004
-
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
Study
EGAS00001007017
-
Neuroblastoma heterogeneity
Study
EGAS00001007019
-
Molecular features of adenomas predicting metachronous colorectal cancer: a nested-case control study
Study
EGAS00001007039
-
Methylation-based classification of human mesenchymal chondrosarcoma
Study
EGAS00001007042
-
Whole genome and whole exome sequencing of serial biopsies of relapsed/refractory diffuse large B-cell lymphoma.
Study
EGAS00001007053
-
PEACE melanoma 14
Study
EGAS00001007081
-
Multiple Myeloma follow-up sequencing study
Study
EGAS00001007092
-
BMP4 and temozolomide synergize in the majority of patient derived glioblastoma cultures
Study
EGAS00001007095
-
Transcriptomic analysis of liver CD8+ T cells
Study
EGAS00001006885
-
Whole Exome Sequencing data of six chRCC tumors corresponding to three patients
Study
EGAS00001007104
-
Single-cell and bulk RNA-sequencing of nivolumab-treated glioblastoma
Study
EGAS00001007110
-
Human lymphoma plasma cfRNA - raw data
Study
EGAS00001007127
-
Spatial and temporal transcriptomics of medulloblastoma with chromothripsis identifies multiple genetic clones that resist to treatment and lead to relapse
Study
EGAS00001007128
-
Monocyte Spike-in RNASeq
Study
EGAS00001007197
-
Establishment and characterization of an Epstein-Barr virus-positive cell line from a non-keratinizing differentiated primary nasopharyngeal carcinoma
Study
EGAS00001007172
-
Chip_seq_oesophageal_adenocarcinoma_
Study
EGAS00001007180
-
3D-GSC_expression_profiles
Study
EGAS00001007182
-
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
Study
EGAS00001007210
-
Multiomic profiling of pleomorphic rhabdomyosarcoma
Study
EGAS00001007230
-
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Study
EGAS00001007245
-
Transcriptomic analysis of cell-of-origin CNS neuroblastoma, FOXR2 activated
Study
EGAS00001007247
-
Whole genome sequencing of patients with or at risk for HCC
Study
EGAS00001007249
-
Methylome profiling of epithelioid sarcoma
Study
EGAS00001007257
-
Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM
Study
EGAS00001007286
-
Proteomic Analysis of Non-Muscle Invasive and Muscle Invasive Bladder Cancer Highlights Distinct Subgroups With Metabolic, Matrisomal, and Immune Hallmarks
Study
EGAS00001007290
-
The genomic landscape of recurrent ovarian high grade serous carcinoma: the BriTROC-1 study
Study
EGAS00001007292
-
RNAseq of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007300
-
WES of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007301
-
Serial TERT rearrangement breakpoint quantification in circulating tumor DNA enables minimal residual disease monitoring in patients with neuroblastoma
Study
EGAS00001007365
-
Complex structural variation patterns in pediatric solid tumors
Study
EGAS00001007565
-
shallow WGS and deep targeted panel on ctDNA in rhabdomyosarcomas
Study
EGAS00001007399
-
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types
Study
EGAS00001007412
-
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
Study
EGAS00001007426
-
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types (RNAseq)
Study
EGAS00001007428
-
Genomic characterization of hepatocellular carcinoma in Hispanic patients
Study
EGAS00001007431
-
Machine Learning Signal Enrichment for Ultrasensitive Plasma Tumor Burden Monitoring
Study
EGAS00001007451
-
Genome-wide DNA Methylation Analysis Reveals a Unique Methylation Pattern for Pleural Mesothelioma Compared to Healthy Pleura and Other Lung Diseases
Study
EGAS00001007783
-
Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages by treatment with GW2580
Study
EGAS00001007466
-
Epithelioid haemangioendothelioma (EHE) case series from the Stafford Fox Rare Cancer Program
Study
EGAS00001007474
-
Single-cell profiling of co-cultures of GSCCs and macrophages
Study
EGAS00001007482
-
ExomeSeq Neoantigen Immunogenicity Landscapes
Study
EGAS00001007508
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
Study
EGAS00001007545
-
Single-cell RNA-seq of peripheral blood mononuclear cells in classic Hodgkin lymphoma
Study
EGAS00001007569
-
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
Study
EGAS00001007585
-
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
Study
EGAS00001007611
-
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma
Study
EGAS00001007650
-
Comprehensive Deep Sequencing Atlas in HCC tumors
Study
EGAS00001007694
-
Genomic and transcriptomic landscape of T-cell lymphoblastic lymphoma compared to T-cell acute lymphoblastic leukemia: similar subtypes and different fusions
Study
EGAS00001007767
-
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Study
EGAS00001007873
-
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Study
EGAS00001007911
-
Ewing and Ewing-like-sarcoma tumoroid biobank reveals distinct drug sensitivities: translocation makes the difference
Study
EGAS00001007941
-
Preclinical Pediatric Molecular Analysis for Therapy Choice (MATCH)
Study
EGAS00001008011
-
Three-dimensional patient-derived models of glioblastoma retain intra-tumoral heterogeneity
Study
EGAS00001008023
-
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target
Study
EGAS00001008039
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_ATAC
Study
EGAS00001008083
-
Segmental_cherry_angioma_case
Study
EGAS00001008212
-
Cross-species Comparison Reveals Therapeutic Vulnerabilities Halting Glioblastoma Progression
Study
EGAS00001008155
-
Molecular characterisation of paediatric PDX cells before and after 3D RASTRUM bioprintin
Study
EGAS00001008220
-
Whole exome sequencing data for paired non-serous endometrial and ovarian carcinomas from 27 patients with concurrent tumours.
Study
EGAS00001008259
-
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
Study
EGAS00001007002
-
Molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (N2M2/NOA-20 phase I/IIa umbrella trial)
Study
EGAS00001008033
-
IMMUcan Upstream SCCHN3 cohort
Study
EGAS50000001505